A detailed history of Morgan Stanley transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Morgan Stanley holds 644,335 shares of WVE stock, worth $9.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
644,335
Previous 837,014 23.02%
Holding current value
$9.16 Million
Previous $4.18 Million 26.51%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$5.12 - $9.01 $986,516 - $1.74 Million
-192,679 Reduced 23.02%
644,335 $5.28 Million
Q2 2024

Oct 17, 2024

SELL
$4.38 - $6.48 $473,504 - $700,526
-108,106 Reduced 11.44%
837,014 $4.18 Million
Q2 2024

Aug 14, 2024

SELL
$4.38 - $6.48 $473,504 - $700,526
-108,106 Reduced 11.44%
837,014 $4.18 Million
Q1 2024

Oct 17, 2024

BUY
$3.54 - $6.84 $382,695 - $739,445
108,106 Added 12.92%
945,120 $5.83 Million
Q1 2024

Aug 16, 2024

BUY
$3.54 - $6.84 $2.67 Million - $5.16 Million
754,792 Added 396.57%
945,120 $5.83 Million
Q1 2024

May 15, 2024

BUY
$3.54 - $6.84 $2.67 Million - $5.16 Million
754,792 Added 396.57%
945,120 $5.83 Million
Q4 2023

Aug 16, 2024

SELL
$4.16 - $6.87 $2.69 Million - $4.44 Million
-646,686 Reduced 77.26%
190,328 $961,000
Q4 2023

Feb 13, 2024

BUY
$4.16 - $6.87 $417,917 - $690,167
100,461 Added 111.79%
190,328 $961,000
Q3 2023

Nov 15, 2023

SELL
$3.56 - $5.75 $27,198 - $43,930
-7,640 Reduced 7.84%
89,867 $516,000
Q2 2023

Aug 14, 2023

SELL
$3.51 - $4.69 $821,189 - $1.1 Million
-233,957 Reduced 70.58%
97,507 $354,000
Q1 2023

May 15, 2023

BUY
$3.58 - $6.3 $843,043 - $1.48 Million
235,487 Added 245.36%
331,464 $1.44 Million
Q4 2022

Feb 14, 2023

BUY
$3.18 - $7.0 $200,982 - $442,414
63,202 Added 192.84%
95,977 $671,000
Q3 2022

Nov 14, 2022

SELL
$2.37 - $4.28 $118,127 - $213,328
-49,843 Reduced 60.33%
32,775 $119,000
Q2 2022

Oct 27, 2022

SELL
$1.23 - $3.25 $33,071 - $87,382
-26,887 Reduced 24.55%
82,618 $267,000
Q2 2022

Aug 15, 2022

SELL
$1.23 - $3.25 $33,071 - $87,382
-26,887 Reduced 24.55%
82,618 $267,000
Q1 2022

Oct 27, 2022

BUY
$2.0 - $3.28 $53,774 - $88,189
26,887 Added 32.54%
109,505 $220,000
Q1 2022

May 13, 2022

SELL
$2.0 - $3.28 $482,932 - $792,008
-241,466 Reduced 68.8%
109,505 $220,000
Q4 2021

Feb 14, 2022

BUY
$3.14 - $5.15 $745,238 - $1.22 Million
237,337 Added 208.86%
350,971 $1.1 Million
Q3 2021

Nov 15, 2021

BUY
$4.89 - $7.12 $555,670 - $809,074
113,634 New
113,634 $557,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.23B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.